abstract |
The present description relates to an inhibitory RNA molecule, comprising an oligonucleotide that selectively knocks down expression a NANOG pseudogene expressed in many human cancers, a replicating viral vector capable of encoding such inhibitory RNA molecule, pharmaceutical compositions comprising said vector, and methods of treating cancer by administration of said pharmaceutical composition. |